Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients

NCT ID: NCT00787631

Last Updated: 2008-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-12-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A high number of birch pollen-allergic individuals develop hypersensitivity reactions to certain foods, e.g. apples. This food allergy is due to immunological cross-reactivity. Birch pollen-related foods contain proteins, e.g. Mal d 1 in apple, that are structurally related with the major birch pollen allergen, Bet v 1. Hence IgE antibodies and T lymphocytes specific for Bet v 1 recognize these food proteins which results in activation of the immune system and, consequently, in clinical symptoms.

In the present study the investigators intend to investigate if and how the consumption of birch pollen-related food allergens affects birch pollen allergy. In other words, the investigators are interested to analyse whether Bet v 1-related food allergens activate Bet v 1-specific memory cells and thus, contribute to the maintenance of the pollen allergy outside the pollen season. Data obtained in this study will help to clarify the immunological and clinical role of cross-reactivity between pollen and food allergies and will reveal whether avoidance of such foods should be recommended for the patients. Finally, novel approaches for diagnosis and therapy of pollen-related food allergens can be developed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis Food Allergy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

birch pollen pollen allergy oral allergy syndrome to apple cross reactivity bet v 1 mal d 1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Otherwise healthy birch pollen allergic (rhinoconjunctivitis)persons
* Positive SPT and RAST to birch pollen
* Sensitized to Bet v 1

Exclusion Criteria

* Persons suffering from malignancies, autoimmune and cardiopulmonary diseases
* Anemia
* Hyper-IgE syndrome
* Treatment with ß-blockers, permanent treatment with antihistaminics, leucotriene antagonists, corticosteroids
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DIAID, Dep. of Dermatology, MUV

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tamar Kinaciyan, Ass Prof MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Dermatology, Medical University of Vienna

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tamar Kinaciyan, Ass.Prof.MD

Role: CONTACT

Phone: +43140400

Email: [email protected]

Barbara Bohle, AssocProf Dr

Role: CONTACT

Phone: +43140400

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TK01/2008

Identifier Type: -

Identifier Source: org_study_id